201
Views
26
CrossRef citations to date
0
Altmetric
Original Research

Second-generation aptamer-conjugated PSMA-targeted delivery system for prostate cancer therapy

, , , , , , , , , , , , & show all
Pages 1747-1756 | Published online: 19 Aug 2011

References

  • EllingtonADSzostakJWIn vitro selection of RNA molecules that bind specific ligandsNature199034662878188221697402
  • TuerkCGoldLSystematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymeraseScience199024949685055102200121
  • WuFWuenschSAAzadnivMEbrahimkhaniMRCrispeINGalactosylated LDL nanoparticles: A novel targeting delivery system to deliver antigen to macrophages and enhance antigen specific T cell responsesMol Pharm2009651506151719637876
  • IshidaSUsuiTYamashiroKVEGF164-mediated inflammation is required for pathological, but not physiological, ischemia-induced retinal neovascularizationJ Exp Med2003198348348912900522
  • BrodyENGoldLAptamers as therapeutic and diagnostic agentsJ Biotechnol200074151310943568
  • LupoldSEHickeBJLinYCoffeyDSIdentification and characterization of nuclease-stabilized RNA molecules that bind human prostate cancer cells via the prostate-specific membrane antigenCancer Res200262144029403312124337
  • ChengJTeplyBASherifiIFormulation of functionalized PLGA-PEG nanoparticles for in vivo targeted drug deliveryBiomaterials200728586987617055572
  • FarokhzadOCJonSKhademhosseiniATranTNLavanDALangerRNanoparticle-aptamer bioconjugates: A new approach for targeting prostate cancer cellsCancer Res200464217668767215520166
  • DharSGuFXLangerRFarokhzadOCLippardSJTargeted delivery of cisplatin to prostate cancer cells by aptamer functionalized Pt(IV) prodrug-PLGA-PEG nanoparticlesProc Natl Acad Sci USA200810545173561736118978032
  • TongRYalaLFanTMChengJThe formulation of aptamer-coated paclitaxel-polylactide nanoconjugates and their targeting to cancer cellsBiomaterials201031113043305320122727
  • DassieJPLiuXYThomasGSSystemic administration of optimized aptamer-siRNA chimeras promotes regression of PSMA-expressing tumorsNat Biotechnol200927983984919701187
  • KimEJungYChoiHProstate cancer cell death produced by the co-delivery of Bcl-xL shRNA and doxorubicin using an aptamer-conjugated polyplexBiomaterials201031164592459920206379
  • ChoiYJKangSJKimYJLimYBChungHWComparative studies on the genotoxicity and cytotoxicity of polymeric gene carriers polyethylenimine (PEI) and polyamidoamine (PAMAM) dendrimer in Jurkat T-cellsDrug Chem Toxicol201033435736620550436
  • MortimerMKasemetsKHeinlaanMKurvetIKahruAHigh throughput kinetic Vibrio fischeri bioluminescence inhibition assay for study of toxic effects of nanoparticlesToxicol In Vitro20082251412141718400463
  • JangSHChoiSJOhJHNonviral gene delivery to human ovarian cancer cells using arginine-grafted PAMAM dendrimerDrug Dev Ind Pharm2011371414620950058
  • BeyerleAIrmlerMBeckersJKisselTStoegerTToxicity pathway focused gene expression profiling of PEI-based polymers for pulmonary applicationsMol Pharm20107372773720429563
  • ZhangXQWangXLHuangSWIn vitro gene delivery using polyamidoamine dendrimers with a trimesyl coreBiomacromolecules20056134135015638538
  • LuoDHaverstickKBelchevaNHanESaltzmanWMPoly(ethylene glycol)-conjugated PAMAM dendrimer for biocompatible, high-efficiency DNA deliveryMacromolecules200235934563462
  • BraunCSVetroJATomaliaDAKoeGSKoeJGMiddaughCRStructure/function relationships of polyamidoamine/DNA dendrimers as gene delivery vehiclesJ Pharm Sci200594242343615614818
  • DingHYongKTRoyIGold nanorods coated with multilayer polyelectrolyte as contrast agents for multimodal imagingJ Phys Chem C2007111341255212557
  • BonoiuACMahajanSDDingHNanotechnology approach for drug addiction therapy: Gene silencing using delivery of gold nanorod-siRNA nanoplex in dopaminergic neuronsProc Natl Acad Sci U S A2009106145546555019307583
  • ZhangZQPanBFWangKElectrochemical property and cell toxicity of gold electrode modified by monolayer PAMAM encapsulated gold nanorodsNano Biomed Eng201023182188
  • KawasakiHWadhwaRTairaKWorld of small RNAs: From ribozymes to siRNA and miRNADifferentiation2004722–3586415066185
  • PontesOPikaardCSsiRNA and miRNA processing: New functions for Cajal bodiesCurr Opin Genet Dev200818219720318337083
  • LinSLChangDYingSYAsymmetry of intronic pre-miRNA structures in functional RISC assemblyGene2005356323816005165
  • BonciDCoppolaVMusumeciMThe miR-15a-miR-16-11 cluster controls prostate cancer by targeting multiple oncogenic activitiesNat Med200814111271127718931683
  • CleversHWnt/beta-catenin signaling in development and diseaseCell2006127346948017081971
  • DhanasekaranSMBarretteTRGhoshDDelineation of prognostic biomarkers in prostate cancerNature2001412684982282611518967
  • SherrCJCancer cell cyclesScience19962745293167216778939849
  • HuangRKeWLiuYJiangCPeiYThe use of lactoferrin as a ligand for targeting the polyamidoamine-based gene delivery system to the brainBiomaterials200829223824617935779
  • NamaHYNamaKHahnHJBiodegradable PAMAM ester for enhanced transfection efficiency with low cytotoxicityBiomaterials200930466567318996585
  • BagalkotVFarokhzadOCLangerRJonSAn aptamer-doxorubicin physical conjugate as a novel targeted drug-delivery platformAngew Chem Int Ed Engl200645488149815217099918
  • FischerDLiYAhlemeyerBKrieglsteinJKisselTIn vitro cytotoxicity testing of polycations: Influence of polymer structure on cell viability and hemolysisBiomaterials20032471121113112527253